Quarterly Activities/Appendix 4C Cash Flow Report

• New CEO and board changes to support growth strategy
• Revenue increased 12.9% QoQ to $1.210m, 42.4% YoY
• Activated licences and ARR up 1.2% QoQ, 27.3% and 31.1% YoY
• Customer retention improved to 90%
• New contracts in US and UK, expanding existing agreements

PainChek Ltd has reported its quarterly activities for the three months ended 30 September 2026, highlighting progress in its commercial strategy and customer wins. The company introduced a revised commercial strategy focusing on priority residential aged care markets in the US and UK, supported by leadership and board changes. CEO Karen Holzberger, appointed in August, leads a team assessing opportunities to convert potential into performance. PainChek's focus on residential aged care is supported by clinical and healthcare economics evidence. The company has over 91,000 activated licences and $4.514m in activated ARR, with a 90% customer retention rate. Revenue increased 12.9% QoQ to $1.210m, reflecting historical agreements and new wins. Key wins include Sabra's expansion to 23 sites, a Silverado paid pilot, and a new Hallmark agreement. The company is also working on deeper integration with PointClickCare and exploring opportunities through the Mayo Clinic Platform Accelerate programme.

PainChek aims to turn commercial momentum into sustained growth, focusing on disciplined execution and clear reporting to shareholders.